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Abstract Pituitary apoplexy (PA) is a rare and potentially
fatal clinical condition presenting acute headache, vomiting,
visual impairment, ophthalmoplegia, altered mental state and
possible panhypopituitarism. It mostly occurs in patients with
haemorrhagic infarction of the pituitary gland due to a pre-
existing macroadenoma. Although there are pathological and
physiological conditions that may share similar imaging char-
acteristics, both clinical and imaging features can guide the
radiologist towards the correct diagnosis, especially using
magnetic resonance imaging (MRI). In this review, we will
describe the main clinical and epidemiological features of PA,
illustrating CT and MRI findings and discussing the role of
imaging in the differential diagnosis, prognosis and follow-up.
Teaching points
• Headache, ophtalmoplegia and visual impairment are fre-
quent symptoms of pituitary apoplexy.
• CT is often the first imaging tool in PA, showing areas of
hyperdensity within the sellar region.
• MRI could confirm haemorrhage within the pituitary gland
and compression on the optic chiasm.
• Frequent simulating conditions are aneurysms, Rathke cleft
cysts, craniopharingioma and mucocele.
• The role of imaging is still debated and needs more studies.
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Introduction
Pituitary apoplexy (PA) was first described by Pearce Bailey in
1898 [1] and recognised as a defined clinical syndrome by
Brougham et al. in 1950 [2]. It is a severe and potentially fatal
medical condition characterised by the variable association of
headache, vomiting, visual impairment, ophthalmoplegia, al-
tered mental state and panhypopituitarism [2–5]. The syndrome
is often related to haemorrhagic infarction of the pituitary gland,
usually in a condition of a pre-existing macroadenoma [6–8]
occurring in 1.6 to 2.8 % of patients with this neoplasm. In a
consistent number of patients with PA, this clinical syndrome
represents the first sign of a previously undetected adenoma.
Few cases of apoplexy have been reported in patients without a
previous pituitary pathology [9, 10] such as Sheehan syndrome,
a condition characterised by pituitary infraction occurring in
post- or peripartum females with hypovolaemia [11–13].
The diagnosis of PA can be made only when haemorrhagic
infarction of the pituitary gland leads to the previously de-
scribed clinical syndrome; the use of the term PA should be
avoided in asymptomatic patients. In fact, huge haemorrhages
can be a common finding in patients with macroadenomas
without PA symptoms [14, 15].
Many clinical series of patients with PA have been report-
ed, while its imaging features are less frequently described.
Because of the potential severe prognosis of PA, radiologists
should be aware of its imaging characteristics on both com-
puted tomography (CT) and magnetic resonance imaging
(MRI), being able to recognise the main conditions that may
mimic PA, from a clinical and radiological perspective.
Definition, clinical features and pathogenesis
Based on the above-mentioned clinical definition, PA is a
rare event and occurs in 1.6 to 2.8 % of patients with
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macroadenomas; it is more frequent in males, with a
gender ratio of 2:1 and a mean age of onset of 57 years
[5, 16–18]. About 60 % of patients with PA may not be
aware of having a pituitary adenoma before the acute
event.
Pituitary apoplexy has a wide spectrum of clinical
manifestations; based on many reports, the most common
symptom is headache, with an incidence of 90–97 %
[2–5, 19]. This is often described as a sudden, severe
head pain, frequently retro-orbital in location [20], that
includes PA into the differential diagnosis of a condition
known as “thunderclap headache”. This comprehends im-
portant and more frequent diseases such as subarachnoid
haemorrhage, cerebral venous sinus thrombosis or cervi-
cal artery dissection [21].
The second most frequent symptom is the visual defi-
cit, ranging from 50 to 82 % of cases [5, 13, 20–25],
followed by nausea, vomiting, ocular palsy and
meningism (25–50 %).
Many authors described that PA is strictly associated
with a sudden enlargement of a pre-existing pituitary
adenoma, resulting in a disturbance of the residual pitui-
tary function and local mass effect on surrounding struc-
tures or, less frequently, in a sudden increase of intracra-
nial pressure [5, 16, 26–28]. Meningeal irritation occurs if
blood gains access to the suprasellar cisterns through a
dilated diaphragm sellae [5].
Many known factors predispose patients to symptom-
atic infarction of the pituitary, amongst which the most
important are hypertension [10, 20], diabetes mellitus
[29], pituitary function dynamic tests [30, 31], adminis-
tration of anticoagulants, bromocriptine, oestrogens
[32–34] and radiotherapy [35]. The pathogenesis under-
lying pituitary apoplexy is still unknown. A possible
mechanism can be the subacute, excessive growth of
the pre-existing adenoma, which outgrows its blood sup-
ply with eventual ischaemic necrosis followed by haem-
orrhage [2, 35]. Indeed, pathologic and dynamic imaging
studies [36, 37] have shown that macroadenomas, as well
as microadenomas, are less vascularised than the pitui-
tary gland, so that a relatively fast and sizable growth
can exceed this low blood supply. However, this theory
does not explain the onset of PA in patients with small
adenomas or with a healthy pituitary. Another hypothesis
is that tumour compression of the infundibulum and
superior pituitary arteries may cause infarction of the
normal pituitary gland; however, ischaemia of the tumour
mass itself is less probable in this case because the
vessels supplying the adenoma are attributable to the
inferior pituitary circulation [38]. Therefore, pituitary
tumours probably suffer from an intrinsic vasculopathy
that can lead to spontaneous infarction and haemorrhage
[4, 22, 23, 39].
Imaging findings
Computed tomography
Most of the patients with symptoms related to PAwill undergo
computed tomography (CT) in an emergency setting. It is
likely that, in most of them, the clinical suspicion might
something other than PA. CT is effective in visualising pitu-
itary expansive lesions leading to sellar enlargement (up to
94 % of cases) [5, 20, 25]. Because of the haemorrhagic
component in most of PAs, CTwill show patchy or confluent
areas of hyperdensity within a pituitary lesion (Fig. 1) [5, 14,
20, 25]. Although a hyperdense lesion inside the sella turcica
tends to represent PA in the proper clinical setting, diseases
other than PA may lead to similar radiological pictures. The
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Fig. 1 CTappearance of pituitary apoplexy. Arrows on axial (a), coronal
(b) and sagittal (c) reconstructions indicate an intrasellar lesion, dis-
homogeneously hyperdense, due to the presence of haemorrhagic
components. The utility of reformatted images in the evaluation of the
intrasellar hyperdensity is evident
most common hyperdense lesions in the pituitary region are
aneurysms, meningiomas, Rathke cleft cysts, germinomas and
lymphoma. They can be easily differentiated from blood using
MRI. After administration of contrast medium, a rim of en-
hancement may be the sign of pituitary apoplexy [40]. The
real accuracy of CT in the diagnosis of PA is not fully de-
scribed, being dependent on the time of imaging from onset of
symptoms and on technical characteristics of CT itself. Some
authors demonstrated a low sensitivity of CT in detecting
pituitary tumour haemorrhage; this ranges from 21 % [20] to
46 % [16]. A possible explanation for these wide ranges is
related to blood degradation, leading to a decreased densi-
ty, in the days following the acute onset. For this reason,
making the distinction between cystic or degenerative
changes inside a pituitary neoplasm and a subacute haem-
orrhage may be impossible [14]. Based of the above-
mentioned data, it is important to remember that the CT
examination may be normal, underestimated or non-patho-
gnomonic, especially in those rare patients with non-
haemorrhagic PA or without a pre-existing pituitary ade-
noma. Therefore, although CT can exclude other diseases
(i.e. subarachnoid haemorrhage), an MR examination can
give more details about a suspected PA [14, 20].
Magnetic resonance imaging
Magnetic resonance imaging (MRI) is the most important tool
in the diagnosis of PA, being able to identify the presence of
an adenoma and its haemorrhagic degeneration. MRI is defi-
nitely superior to CT in the diagnosis of PAwith a sensitivity
ranging from 88 % to 90 % [18, 41]. Recently, Semple et al.
demonstrated that MRI features of PA correlate with the
Fig. 2 MRI performed in a patient with acute headache, mydriasis and
visual impairment shows acute/early subacute phase haemorrhagic in-
farction within a pituitary macroadenoma. The intrasellar mass appears
slightly hyperintense on unenhanced T1WI (axial, a; coronal, b; sagittal,
c) with areas of hypointense signal on T2WI (axial, d; coronal, e) because
of the presence of deoxyhaemoglobin. Coronal T1 contrast-enanched
images (f) show left cavernous sinus involvement, probably leading to
visual symptoms
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pathologic reports and operative findings and that PA features
can be accurately predicted from MR imaging [14].
It is well known that the signal of blood clots in MRI
changes over time. In the acute phase (0–7 days),
deoxyhaemoglobin leads to shortening of the T2 relaxation
time due to the susceptibility effect and the MRI signal is
hypointense on T2-weighted imaging (T2W1) with
isointensity or slight hypointensity on T1-weighted imaging
Fig. 3 Large pituitary macroadenoma withMRI signs of subacute haem-
orrhage. In this phase, haemorrhage appears hyperintense on both T1WI
(b) and T2WI (a). In the T2WI (a, e), thickening of the sphenoid mucosa
(arrow) is evident as well. This sign is highly specific for pituitary
apoplexy. On contrast-enhanced MRI (c, d, f) the residual pituitary gland
enhances (arrow in c compared to b). Note the optic pathway compres-
sion, more evident on T2WI
Fig. 4 The figure shows an oval-shaped, haemorrhagic lesion within a
pituitary adenoma, homogeneously hyperintense on both T1- and T2-
weighted images (WI) (a), with a hypointense rim on T2WI (b, white
arrow). Contrast-enhanced T1WI (c) shows strong, homogeneous en-
hancement of the pituitary gland and stalk, both displaced by the tumour
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(T1WI) (Fig. 2). In the subacute phase (7–21 days),
methaemoglobin shortens the T1 relaxation time and the
haemorrhage will appear hyperintense on T1WI as well as
on T2WI (Figs. 3 and 4). In the chronic phase (>21 days),
macrophages digest the clot and the presence of haemosiderin
and ferritine causes a strong hypointensity on both T1WI and
T2WI [42–44].
First, Poitin et al. and, more recently, Dubuisson et al.
described the MRI features in a group of patients with PA
[5, 45]. MRI predominantly showed an intra- and suprasellar
expanding mass with different signal intensities on T1WI and
T2WI, depending on the presence of haemorrhage and on its
stage, as described above. In most cases, MRI performed
during the acute phase of the clinical syndrome shows areas
of hyperintensity on T1W1, generally more pronounced in the
peripheral area of the lesions [45]. After IV gadolinium ad-
ministration, a slight and inhomogeneous contrast enhance-
ment is evident (Figs. 3c, f, 4) but often is difficult to differ-
entiate from normal residual pituitary gland [5, 14, 45, 46].
T2WI showed areas of mixed high and low signal intensity,
with the presence of a possible thin peripheral ring of marked
hypointensity, representing haemosiderin and ferritin de-
position. The latter must be considered an unusual and
unexpected finding, since pituitary tumours lack a blood-
brain barrier, and the accumulation of macrophages con-
taining haemosiderin normally does not occur [45].
T2WIs are even useful in the evaluation of potential
compressions of the optic chiasm and hypothalamus by
the tumour [40].
Many authors [5, 14, 45] described the possibility of a fluid
debris level within the mass. Poitin et al. made a pathological-
radiological correlation in their patients with this finding,
showing that the upper fluid (hyperintense on T1W1) contains
free extracellular meta-Hb and the lower layer (iso-
hypointense on T1WI) corresponds to a sediment of red blood
remnants [45]. This finding is suggestive of late subacute
haemorrhage and is considered a specific sign of pituitary
apoplexy [45–47].
Another important MRI finding that is highly indicative of
PA is the thickening of sphenoid sinus mucosa (Fig. 3a) [14,
46, 48]. This condition may be related to venous engorgement
in this region, a reversible condition on follow-up studies [14].
Fig. 5 Aneurysm of the carotid
siphon as shown on contrast-
enhanced T1WI (a, arrows).
Axial and coronal T2WI (b, c)
show the presence of a




reconstruction (d) clearly shows
the exact nature of the lesion
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Thus, this is considered a specific finding of the acute phase of
haemorrhage.
Less is known about the MRI appearance of pituitary
apoplexy without haemorrhagic infarction. Ostrov et al. found
that this condition may appear as low signal intensity on both
T1WI and T2WI, without contrast enhancement inside the
lesion but with a peripheral rim of enhancement [49]. It has
been reported that diffusion-weighted images may help to
visualise areas of infarction within a non-haemorrhagic pitu-
itary lesion [15] but obtaining good DWI images in the
pituitary region is challenging because of susceptibility
artefacts.
The use of T2*-weighted gradient-echo (GE) MR imag-
ing is currently the most sensitive neuroimaging technique
for the identification of brain haemorrhage. T2*-weighted
images are highly sensitive to the paramagnetic effects of
deoxy-HB and meta-HB and show bleeding products and
haemosiderin deposits as areas of strongly hypointense
signal. Tosaka et al. recently demonstrated that this state-
ment could be applied even to PA [50]. GE MR can depict
acute and chronic haemorrhages not seen with convention-
al SE techniques. These can appear as a hypointense rim,
mass, spot or diffused area of lower signal intensity. The
latter, diffused, is related to pituitary adenomas without a
history of headache or clinical PA.
Differential diagnosis
MRI is a useful tool in the differential diagnosis of pituitary
apoplexy. Many conditions can present with hyperintensity
on T1WI in the sellar region, the most frequentMRI feature of
PA [46]. Thus, it is important to use advancedMRI techniques
such as T2*GE together with a careful search for specific
radiological findings, such as fluid levels or thickening of
the sphenoid mucosa.
The posterior lobe of the pituitary gland usually appears as
a hyperintense spot on T1WI because of storage of vasopres-
sin [51–53]; this is a normal finding and should not be con-
fused with a haemorrhage within the gland.
In the case of anterior pituitary lobe hyperactivity, the gland
may be hyperintense [54, 55]. In these cases, haemorrhage can
be easily excluded with the evaluation of T2WI and T2*WI.
Another condition to consider for the differential diagnosis
is the presence of an aneurysm (Fig. 5). Aneurysms arising
from the carotid siphon or from the anterior communicating
artery usually appear as round lesions, hypointense on T2WI
Fig. 6 Suprasellar RCC appears hyperintense on T1WI (a, b) without
contrast enhancement (d). On coronal T2WI (c), an arrow indicates an
intracystic hypointense nodule, a typical sign of RCC, related to
proteinaceous concretion. MR angiography (e) can be useful to rule out
the possibility of an aneurysm, but the cyst will appear mildly hyperin-
tense on MIP reconstruction
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because of flow void. Partially thrombosed aneurysm in the
sellar region can show high signal intensity on T1WI [46].
Thus, an imaging study should be completed with MR angi-
ography, which is best with a contrast-enhanced technique, to
exclude this pathology [25].
Rathke cleft cysts (RCCs) occur with T1 hyperintensity
because of the variable protein content [56] (Fig. 6). RCC,
which can be either intra- or suprasellar, is usually located
along the midline and does not present a fluid debris level
[40]. A hypointense intracystic nodule on T2WI, related to
concretion of proteinaceous material within the RCC, is typ-
ical (Fig. 6c). The variable MRI appearance of RCC may
cause difficulties in the differential diagnosis with PA.
Moreover, a large suprasellar RCC may mimic PA even
clinically, with acute onset of headache and visual deficit, as
described by the recent work of Binning et al. [57].
Craniopharingioma is another pathology that can be diffi-
cult to distinguish from PA. It is usually an intra-/suprasellar
lesion with variable solid, cystic and calcified components
[40, 58]. The cystic component may contain a proteinaceous
fluid, appearing hyperintense on T1WI, and mimicing
haemorrhagic degeneration. Careful evaluation of T2WI to-
gether with the acquisition of a CT scan to rule out calcific
components can help to obtain the correct diagnosis [40].
Other conditions that can simulate PA on imaging are
lipoma, dermoid cysts and postoperative changes. Lipoma
and dermoid cysts contain fat and can be confirmed with fat-
suppressed images. Anyway, these pathologies do not usually
appear with the clinical syndrome of PA.
Role of imaging in prognosis, therapy and follow-up
In clinical practice, many endocrinologists and pituitary sur-
geons believe that patients presenting with ophthalmoplegia
(typically III palsy) without visual field loss may safely be
monitored conservatively—typically with spontaneous full
recovery of the ophthalmoplegia after several weeks and very
often with substantial shrinkage of the pituitary mass on the
follow-up scan some months later.
The role of imaging, in particular of MRI, in the decision-
making process for a proper therapy is still debated and
Fig. 7 Pituitary apoplexy in a patient with pre-existing adenoma. Arrows
on sagittal and coronal T2WI (a, b) as well as in coronal T1WI show an
area of haemorrhage within the adenoma. Haemorrhagic components
appear hyperintense on both T2WI and T1WI. In (d) sagittal contrast-
enhanced T1WI showing peripheral enhancement. Despite the absence of
chiasm compression and cavernous sinus involvement, this patient
underwent surgical treatment with a transsphenoidal approach. Sagittal
T1WI follow-up during surgery on intraoperative MRI (Brain Suite) (e)
and late follow-up (3 months later, f) show good imaging results
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probably needs more study. Some authors reported that MRI
findings in patients with PA do not correlate with the severity
of its clinical presentation, in terms of both visual loss and
cranial nerve palsies [25, 45, 50], suggesting that the role of
imaging might be limited. Despite this, in the series of Ayuk
and colleagues, patients undergoingMRI were managed more
safely with conservative treatment because of identification of
areas of haemorrhage and infarction, which on repeated MRI
scanning allows prediction of the evolution of PA [25].
Semple et al. recently described that patients with PA and
MRI findings of pituitary infarction without signs of haemor-
rhage showed a less severe clinical presentation and a better
outcome [14].
Although no study demonstrated that chiasm compression
may represent the most relevant MRI feature, it is likely that
this observation has a clinical impact in the decision-making
process (Fig. 3).
For the above-mentioned reasons, even though the most
important features for treatment decisions (surgical or conser-
vative) are related to the severity of the clinical condition [59],
MRI can offer relevant prognostic information (Figs. 3 and 7).
The recent UK guidelines for the management of PA indi-
cate an urgent MRI in patients with suspected PA as IIIB
evidence class, since more randomised clinical trials are
required. If MRI is contraindicated, a dedicated pituitary mul-
tidetector CT is advisable [59].
Radiological follow upwithMRI in patients affected by PA
is important. The pre-existing adenoma might grow after
bleeding and eventually re-bleed (Fig. 8) [20]. In those pa-
tients treated conservatively, tumour growth after bleeding
occurs within a wide range, as shown by different studies
(from 6 to 90 %), but this indicates the need for clinical
radiological follow-up 3–6 months after PA and every year
for at least 5 years. Recurrent pituitary apoplexy has been
documented in studies with both conservative and surgically
therapeutic approaches, without a significant difference in the
incidence between these groups [25, 60].
Conclusions
PA is a severe clinical syndrome and imaging is important to
rule out other pathologies showing similar symptoms.
Currently, CT is the most commonly used imaging modal-
ity during the acute onset of symptoms consistent with PA.
Despite this, CT lacks sensitivity and MRI should always be
performed if PA is suspected. MRI can evaluate pituitary
infarct and haemorrhage, mass effect and differentiate PA
Fig. 8 Series of coronal T1WI follow-up images in a patient with a
history of pituitary apoplexy. The patient presented to us for observation
in July 2008 with sudden headache (a). He underwent conservative
treatment. Further MRI studies demonstrated progressive reduction of
the haemorrhagic component over time (b, c). Because of a new sudden
episode of headache, he underwent a new follow-up (d) that showed a
new increase in the size of the T1WI hyperintensity, suggesting re-
bleeding. Further follow-up showed a reduction of haemorrhage during
the next 2 years
760 Insights Imaging (2014) 5:753–762
from other pathologies such as a Rathke cleft cyst or
craniopharingioma. Other MR techniques such as MRA,
DWI and T2*-weighted GE images can increase its diagnostic
capabilities.
Although more studies will be necessary to define the role
of MRI in treatment choices and prognostic information, this
modality is a fundamental step in the diagnosis of PA in the
acute phase and is mandatory in the follow-up of these
patients.
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
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